Inhibikase Therapeutics, Inc.
General ticker "IKT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $181.8M (TTM average)
Inhibikase Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -14.3%.
Estimated limits based on current volatility of 4.4%: low 1.87$, high 2.04$
Factors to consider:
- Total employees count: 14 as of 2023
- Top business risk factors: Going concern, Capital raising, Economic downturns and volatility, Pandemic risks, Litigation risks
Short-term IKT quotes
Long-term IKT plot
Financial data not available